Press Releases
Pharma 4.0: CDMOs Digitalize to Enhance Customer Value
“Samsung Biologics has completed the digital connectivity phase, which has enabled the CDMO to provide their biopharma partners with an advanced level of AI-based service,” comments Hyeokgeon Kwon, director of information strategy at Samsung Biologics, a global, fully integrated, end-to-end CDMO, headquartered in Incheon, S. Korea.
“Samsung Biologics has completed the digital connectivity phase, which has enabled the CDMO to provide their biopharma partners with an advanced level of AI-based service,” comments Hyeokgeon Kwon, director of information strategy at Samsung Biologics, a global, fully integrated, end-to-end CDMO, headquartered in Incheon, S. Korea.